Antisense modulation of p38 mitogen activated protein kinase expression
US7981868B2 · kind B2 · utility
3Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2004 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Sep 12, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the treatment and diagnosis of diseases or conditions amenable to treatment through modulation of expression of a gene encoding a p38 mitogen-activated protein kinase (p38 MAPK) are provided. Methods for decreasing airway hyperresponsiveness or airway inflammation in an animal are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.